Work

Adjuvant Therapy Combining Donafenib and Sintilimab Enhances Recurrence‐Free Survival in Hepatocellular Carcinoma Patients With High‐Risk Recurrence Factors After Radical Resection: A Retrospective Cohort Study

Year: 2025

Type: article

Source: MedComm – Oncology

DOI: 10.1002/mog2.70013

Authors: Hanchuan Shen, Bing Liu, Hangyu Zhang, Yang Liu, Chenggang Li

Institutions: Chinese PLA General Hospital, Chinese People's Liberation Army

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4408386445

FWCI:

Cites: 5

Cited by:

Related to: 10